Molecular Mechanisms Underlying the Cardiovascular Toxicity of Specific Uremic Solutes
Mounting evidence strongly suggests a causal link between chronic kidney disease (CKD) and cardiovascular disease (CVD). Compared with non-CKD patients, patients with CKD suffer disproportionately from CVD and derive suboptimal benefits from interventions targeting conventional CVD risk factors. Ure...
Main Authors: | Jonathan D. Ravid, Vipul C. Chitalia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/9/2024 |
Similar Items
-
Uremic toxins. Back to the future
by: I.L. Kuchma
Published: (2021-04-01) -
Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial
by: Amanda de Faria Barros, et al.
Published: (2018-07-01) -
The Impact of CKD on Uremic Toxins and Gut Microbiota
by: Jacek Rysz, et al.
Published: (2021-03-01) -
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
by: Paola Ciceri, et al.
Published: (2021-05-01) -
Role of gut-derived uremic toxins on oxidative stress and inflammation in patients with chronic kidney disease
by: S Gouroju, et al.
Published: (2017-01-01)